InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)
Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –
InfuSystem operating margin
Operating margin is operating income as a percentage of revenue.
InfuSystem's operating margin for the twelve months ending Sep 30, 2026 was 9.8%. For fiscal 2025 it was 8.3%, against 5.1% the year before. The highest annual figure on record is 14.0% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.3% | +3.2 |
| FY2024 | Dec 31, 2024 | 5.1% | +1.9 |
| FY2023 | Dec 31, 2023 | 3.2% | +1.7 |
| FY2022 | Dec 31, 2022 | 1.5% | −1.2 |
| FY2021 | Dec 31, 2021 | 2.8% | −6.3 |
| FY2020 | Dec 31, 2020 | 9.1% | +4.7 |
| FY2019 | Dec 31, 2019 | 4.3% | +3.7 |
| FY2018 | Dec 31, 2018 | 0.6% | +6.0 |
| FY2017 | Dec 31, 2017 | -5.4% | −6.7 |
| FY2016 | Dec 31, 2016 | 1.4% | −8.9 |
| FY2015 | Dec 31, 2015 | 10.3% | −3.7 |
| FY2014 | Dec 31, 2014 | 14.0% | +4.6 |
| FY2013 | Dec 31, 2013 | 9.5% | +6.1 |
| FY2012 | Dec 31, 2012 | 3.4% | +124.8 |
| FY2011 | Dec 31, 2011 | -121.4% | −119.5 |
| FY2010 | Dec 31, 2010 | -2.0% | −15.7 |
| FY2009 | Dec 31, 2009 | 13.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 12.6% | +2.2 |
| Q2 FY2026 | Jun 30, 2026 | 11.2% | +0.8 |
| Q1 FY2026 | Mar 31, 2026 | 4.7% | +2.9 |
| Q4 FY2025 | Dec 31, 2025 | 10.3% | +2.5 |
| Q3 FY2025 | Sep 30, 2025 | 10.4% | +1.2 |
| Q2 FY2025 | Jun 30, 2025 | 10.5% | +5.0 |
| Q1 FY2025 | Mar 31, 2025 | 1.8% | +4.4 |
| Q4 FY2024 | Dec 31, 2024 | 7.7% | +3.8 |
| Q3 FY2024 | Sep 30, 2024 | 9.2% | +3.9 |
| Q2 FY2024 | Jun 30, 2024 | 5.5% | +1.6 |
| Q1 FY2024 | Mar 31, 2024 | -2.6% | −2.3 |
| Q4 FY2023 | Dec 31, 2023 | 3.9% | +0.4 |
| Q3 FY2023 | Sep 30, 2023 | 5.3% | +1.9 |
| Q2 FY2023 | Jun 30, 2023 | 3.9% | +3.2 |
| Q1 FY2023 | Mar 31, 2023 | -0.4% | +1.6 |
| Q4 FY2022 | Dec 31, 2022 | 3.6% | −2.5 |
| Q3 FY2022 | Sep 30, 2022 | 3.5% | +4.8 |
| Q2 FY2022 | Jun 30, 2022 | 0.8% | −2.0 |
| Q1 FY2022 | Mar 31, 2022 | -2.0% | −5.5 |
| Q4 FY2021 | Dec 31, 2021 | 6.0% | +1.9 |
| Q3 FY2021 | Sep 30, 2021 | -1.3% | −14.3 |
| Q2 FY2021 | Jun 30, 2021 | 2.8% | −14.5 |
| Q1 FY2021 | Mar 31, 2021 | 3.6% | +3.4 |
| Q4 FY2020 | Dec 31, 2020 | 4.2% | −1.9 |
| Q3 FY2020 | Sep 30, 2020 | 12.9% | +5.2 |
| Q2 FY2020 | Jun 30, 2020 | 17.3% | +12.4 |
| Q1 FY2020 | Mar 31, 2020 | 0.2% | +2.5 |
| Q4 FY2019 | Dec 31, 2019 | 6.0% | +5.3 |
| Q3 FY2019 | Sep 30, 2019 | 7.7% | +8.3 |
| Q2 FY2019 | Jun 30, 2019 | 4.9% | +6.2 |
| Q1 FY2019 | Mar 31, 2019 | -2.3% | −5.9 |
| Q4 FY2018 | Dec 31, 2018 | 0.7% | +7.7 |
| Q3 FY2018 | Sep 30, 2018 | -0.6% | −3.8 |
| Q2 FY2018 | Jun 30, 2018 | -1.2% | +5.2 |
| Q1 FY2018 | Mar 31, 2018 | 3.6% | +14.7 |
| Q4 FY2017 | Dec 31, 2017 | -6.9% | −4.2 |
| Q3 FY2017 | Sep 30, 2017 | 3.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -6.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -11.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -2.7% | – |
See a number that looks wrong?